FIELD: hepatology. SUBSTANCE: level of C peptide in patient's blood serum is determined and, when its value is superior to 908+/-53 pM, clinical course of liver cirrhosis is jugged of and risk of appearance of bleeding and/or ascites in early phases of disease and duration of disease are estimated. EFFECT: increased prediction accuracy and enabled possibility to predict opportunely beginning of diabetes mellitus-caused liver cirrhosis decompensation. 4 tbl, 3 ex
Authors
Dates
2002-12-27—Published
2001-04-18—Filed